Single-Dose Azithromycin for Genital Lymphogranuloma Venereum Biovar Chlamydia trachomatis Infection in HIV-Infected Women in South Africa: An Observational Study

  • R.P.H. Peters*
  • , L. Maduna
  • , M.M. Kock
  • , J.A. McIntyre
  • , J.D. Klausner
  • , A. Medina-Marino
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We conducted an observational study of lymphogranuloma venereum (LGV) biovar Chlamydia trachomatis infection in HIV-infected women in South Africa. The LGV biovar was detected in vaginal specimens of 17 (20%) of 85 women with C. trachomatis infection; 29% were symptomatic. All cases were negative for the LGV biovar after single-dose azithromycin.
Original languageEnglish
Pages (from-to)e15-e17
Number of pages3
JournalSexually Transmitted Diseases
Volume48
Issue number2
DOIs
Publication statusPublished - 1 Feb 2021

Fingerprint

Dive into the research topics of 'Single-Dose Azithromycin for Genital Lymphogranuloma Venereum Biovar Chlamydia trachomatis Infection in HIV-Infected Women in South Africa: An Observational Study'. Together they form a unique fingerprint.

Cite this